Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain
- PMID: 33264211
- DOI: 10.1097/INF.0000000000003009
Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain
Abstract
Introduction: After the introduction of combination antiretroviral treatment, (ART) mortality in HIV-infected patients has dramatically decreased. However, it is still high in patients at risk, as adolescents transitioning to adult care (AC) without virologic control. The aim of this study was to characterize mortality and comorbidities of perinatally infected HIV (PHIV) patients after transition to AC.
Methods: A multicenter retrospective study from patients included in the CoRISpe-FARO Spanish cohort was conducted. PHIV patients who died after transition to AC between 2009 and 2019 were included. Clinical, immunovirologic characteristics, treatments received, comorbidities and causes of death were described.
Results: Among 401 PHIV patients, 14 died (3.5%). All were Spanish, 11/14 (78.6%) women. The median age at diagnosis was 1.5 years (interquartile range [IQR] 0.5-3.9), at transfer to AC was 18 years [16.1-19.9] and at death was 25.8 years [23.6-27.1]. In pediatric units [pediatric care (PC)], CD4+ nadir was 85 cells/μL [IQR 9.7-248.5] and 6/14 patients were classified as C-clinical stage. During AC, all patients were on C-clinical stage and CD4+ nadir dropped to 11.5 cells/μL [4.5-43.3]. cART adherence was extremely poor: in PC, 8/14 patients registered voluntary treatment interruptions; only one had undetectable VL at transition. In AC, 12/14 patients stopped treatment 2 or more periods of time. All deaths were related to advanced HIV disease. Mental health disorders were observed in 7/14 (50%). Main complications described: recurrent bacterial infections (57.1%), wasting syndrome (42.9%), esophageal candidiasis (28.6%) and Pneumocystis jirovecii pneumonia (28.6%). Four women had 11 pregnancies; 5 children were born (none infected).
Conclusions: Young adults PHIV infected who transition to AC without virologic suppression or proven ability to adhere to ART are at high risk of mortality. Mortality was noted as a consequence of advanced HIV disease, frequent mental health problems and poor adherence to ART.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Griffith D, Jin L, Childs J, et al. Outcomes of a comprehensive retention strategy for youth with HIV after transfer to adult care in the United States. Pediatr Infect Dis J. 2019; 38:722–726
-
- Buchholz B, Niehues T. Lost in transition: a risk factor for mortality in youth living with HIV. Pediatr Infect Dis J. 2020; 39:e14–e16
-
- Fish R, Judd A, Jungmann E, et al.; HIV Young Persons Network (HYPNet). Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Med. 2014; 15:239–244
-
- de Jose MI, Jiménez de Ory S, Espiau M, et al.; Working Groups of CoRISpe and HIV HGM BioBank. A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe). BMC Infect Dis. 2013; 13:2
-
- Foster C, Bamford A, Turkova A, et al.; PENTA Guidelines Writing Group and PENTA Steering Committee. Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV. HIV Med. 2017; 18:133–134
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials